Firmenprofil

hybcell Technologie von Anagnostics Bioanalysis GmbH

Anagnostics specializes in developing systems and tests for research and clinical in-vitro-diagnostics. Our aim is to provide solutions for unmet needs especially in protein and infectious disease diagnostics.

Our products contribute to a better living by boosting life sciences and improving health care and therapeutic concepts.

Anagnostics' vision is to establish hybcell technology, a breakthrough development in microarray technology, in pharmaceutical research and clinical diagnostics.

Located in St. Valentin/Austria, we started our developments in 2005. Our team comprises of specialists in molecular diagnostics, mechatronics and software engineering.